Contemporary Outcomes of Tracheostomy in Patients With Single Ventricle Heart Lesions.

IF 1.1 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Dominic Zanaboni, Sunkyung Yu, Ray Lowery, Carolyn Vitale, Vikram Sood, Kurt R Schumacher
{"title":"Contemporary Outcomes of Tracheostomy in Patients With Single Ventricle Heart Lesions.","authors":"Dominic Zanaboni,&nbsp;Sunkyung Yu,&nbsp;Ray Lowery,&nbsp;Carolyn Vitale,&nbsp;Vikram Sood,&nbsp;Kurt R Schumacher","doi":"10.1177/21501351221133775","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Approximately 0.2% to 2.7% of children with congenital heart disease require a tracheostomy after cardiac surgery with the majority having single ventricle (SV) type heart lesions. Tracheostomy in SV patients is reported to be associated with high mortality. We hypothesized that short- and long-term survival of patients with SV heart disease would vary according to tracheostomy indication.</p><p><strong>Methods: </strong>This is a single center, 20-year, retrospective review of all patients with SV heart disease who underwent tracheostomy. Demographic, cardiac anatomy, surgical, intensive care unit, and hospital course data were collected. The primary outcome was survival following tracheostomy. Secondary outcome was the completion of staged palliation to Fontan.</p><p><strong>Results: </strong>In total, 25 patients with SV heart disease who underwent tracheostomy were included. Indications for tracheostomy included one or more of the following: tracheobronchomalacia (n = 8), vocal cord paralysis (n = 7), tracheal/subglottic stenosis (n = 6), primary respiratory insufficiency (n = 4), diaphragm paralysis (n = 3), suboptimal hemodynamics (n = 2), and other upper airway issues (n = 1). Survival at six months, one year, five years, and ten years was 76%, 68%, 63%, and 49%, respectively. Most patients completed Fontan palliation (64%). Patients who underwent tracheostomy for suboptimal hemodynamics and/or respiratory insufficiency had a higher mortality risk compared to those with indications of upper airway obstruction or diaphragm paralysis (hazard ratio 4.1, 95% confidence interval 1.2-13.7; <i>P</i> = .02).</p><p><strong>Conclusions: </strong>Mortality risk varies according to tracheostomy indication in patients with SV heart disease. Tracheostomy may allow staged surgical palliation to proceed with acceptable risk if it was indicated for anatomic or functional airway dysfunction.</p>","PeriodicalId":23974,"journal":{"name":"World Journal for Pediatric and Congenital Heart Surgery","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal for Pediatric and Congenital Heart Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/21501351221133775","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Approximately 0.2% to 2.7% of children with congenital heart disease require a tracheostomy after cardiac surgery with the majority having single ventricle (SV) type heart lesions. Tracheostomy in SV patients is reported to be associated with high mortality. We hypothesized that short- and long-term survival of patients with SV heart disease would vary according to tracheostomy indication.

Methods: This is a single center, 20-year, retrospective review of all patients with SV heart disease who underwent tracheostomy. Demographic, cardiac anatomy, surgical, intensive care unit, and hospital course data were collected. The primary outcome was survival following tracheostomy. Secondary outcome was the completion of staged palliation to Fontan.

Results: In total, 25 patients with SV heart disease who underwent tracheostomy were included. Indications for tracheostomy included one or more of the following: tracheobronchomalacia (n = 8), vocal cord paralysis (n = 7), tracheal/subglottic stenosis (n = 6), primary respiratory insufficiency (n = 4), diaphragm paralysis (n = 3), suboptimal hemodynamics (n = 2), and other upper airway issues (n = 1). Survival at six months, one year, five years, and ten years was 76%, 68%, 63%, and 49%, respectively. Most patients completed Fontan palliation (64%). Patients who underwent tracheostomy for suboptimal hemodynamics and/or respiratory insufficiency had a higher mortality risk compared to those with indications of upper airway obstruction or diaphragm paralysis (hazard ratio 4.1, 95% confidence interval 1.2-13.7; P = .02).

Conclusions: Mortality risk varies according to tracheostomy indication in patients with SV heart disease. Tracheostomy may allow staged surgical palliation to proceed with acceptable risk if it was indicated for anatomic or functional airway dysfunction.

单心室心脏病变患者气管切开术的当代疗效。
目的:大约0.2%至2.7%的先天性心脏病患儿在心脏手术后需要气管切开术,其中大多数为单心室(SV)型心脏病变。据报道,气管切开术与SV患者的高死亡率有关。我们假设SV心脏病患者的短期和长期生存率会根据气管切开术指征而变化。方法:这是一个单中心,20年,回顾性分析所有接受气管切开术的SV心脏病患者。收集了人口统计、心脏解剖、外科、重症监护病房和住院过程的数据。主要结局是气管切开术后的生存。次要结局是方丹分阶段缓解的完成。结果:共纳入25例行气管切开术的SV心脏病患者。气管造口术的适应症包括以下一种或多种:气管支气管软化症(n = 8)、声带麻痹(n = 7)、气管/声门下狭窄(n = 6)、原发性呼吸功能不全(n = 4)、膈肌麻痹(n = 3)、血流动力学欠佳(n = 2)和其他上呼吸道问题(n = 1)。6个月、1年、5年和10年的生存率分别为76%、68%、63%和49%。大多数患者完成了Fontan姑息治疗(64%)。因血流动力学不佳和/或呼吸功能不全而行气管切开术的患者与有上呼吸道阻塞或膈肌麻痹指征的患者相比,死亡风险更高(风险比4.1,95%可信区间1.2-13.7;p = .02)。结论:SV型心脏病患者的死亡风险因气管切开术指征不同而不同。气管切开术可以在可接受的风险下进行分阶段的手术缓和,如果是解剖性或功能性气道功能障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
11.10%
发文量
128
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信